Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the population screening market?

In the recent years, the market size for population screening has experienced significant growth. It is projected to rise from $29.31 billion in 2024 to $31.46 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The previous growth can be credited to various factors such as disease prevention initiatives, government health policies, escalating healthcare costs, and heightened awareness of diseases.

What will be the population screening market size in the future?

Expectations are high for significant expansion in the population screening market size in the coming years, with projections of growth to $41.51 billion by 2029, at a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this predicted growth during the forecast period include a shift towards personalized medicine, an increase in aging population and chronic diseases, the integration of AI and data analytics as well as the extension of screening access. The forecasting period is also set to witness key trends such as advances in medical technology, genomics, precision screening, telehealth, remote screening, multi-disease screening panels, and an increased focus on health equity and accessibility.

Get your population screening market report here!

https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

What main drivers are fueling expansion in the population screening market?

The escalating rates of cancer are predicted to stimulate the expansion of the population screening market in the future. Cancer occurs when certain cells in the human body grow out of control and spread throughout the body. Population screening methods can successfully diagnose cancer at an earlier stage when it is more curable, and the prognosis is often more favorable. For example, the American Cancer Society Inc., a US-based non-profit health organization, released data in January 2023 stating that there were 608,570 cancer-related deaths in 2022 with nearly 1.9 million new cases of cancer, as compared to the 606,520 cancer fatalities in 2021. As such, the growing incidence of cancer is acting as a catalyst to the expansion of the population screening market.

What key areas define the segmentation of the global population screening market?

The population screening market covered in this report is segmented –

1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation

2) By Gender: Male, Female

3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above

4) By Business: Hospitals, Research Institutes, Diagnostic Labs

Subsegments:

1) By Hardware Equipment: Diagnostic Devices, Sample Collection Devices, Imaging Equipment

2) By Testing Or Lab: Laboratory Testing Kits, Point-Of-Care Testing, Blood And Urine Testing Services

3) By Analytics Or Interpretation: Software Solutions For Data Analysis, Interpretation Services, Reporting Tools

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

Who are the dominant players expanding their reach in the population screening market?

Major companies operating in the population screening market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., Evoq Technologies LLC, LabPLUS

How are evolving market trends shaping population screening Strategies?

In an attempt to improve infant health outcomes through early detection, major corporations in the population screening market are introducing innovative services such as newborn mass screening. This public health initiative involves testing newborns for various genetic, metabolic, hormonal, and functional disorders that may not be immediately noticeable at birth but could potentially cause serious health issues if not addressed. For instance, in May 2024, a contract analysis firm known as Shimadzu Techno-Research Inc., a subsidiary of Shimadzu Corporation, a precision instrument manufacturer based in Japan, initiated a new contract service. This service enables polymerase chain reaction (PCR) testing for expanded newborn mass screening. The tests will screen for ailments such as combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), which currently affect a small number of newborns but necessitate prompt treatment following diagnosis.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12587

Which regions are emerging as leaders in the population screening market?

North America was the largest region in the population screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Cellular Health Screening Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report

Drug Screening Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Security Screening Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/security-screening-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: